SOM Biotech will attend BioBusiness 2012 that will take place from 31 January to 2 February 2012 in London. BioBusiness is the leading high-level BioPharma strategy and bio-partnering conference.
Category Archives: News
SOM Biotech will present the company to private investors during the Biotech Showcase™ and J.P. Morgan Healthcare Conference that will take place from 9th to 12th January 2012 in San Francisco, CA.
SOM presents in the 5th Barcelona Healthcare Investment Forum 2011. The forum has become a meeting point between biotech start-up companies, medical devices and healthcare services and investors.
SOM presents its pipeline to the head of Strategic Research Alliances at Pfizer (UK). The meeting was held on 14 and 15 November at Biocat’s Barcelona headquarters.
SOM presents in the 4th ESADE BAN Investment Forum 2011 in Valencia (Spain). The Investment Forum is designed as a meeting point for those seeking investment opportunities and entrepreneurs with innovative projects looking to finance their business ventures during the initial stages.
SOM filed its 3rd international patent application for the treatment of transthyretin-related amyloidosis (TTR), a fatal and incurable disease designated as an “Orphan disease”.
A second private funding round for 1 Mill € has already been offered by the company to push forward its extensive pipeline of new indications.
SOM Biotech has been invited to present at The Drug Repositioning Conference which is going to take place in San Francisco on July 13-14, 2011. Presentations are only granted by invitation.
Laia Barbosa has joined SOM Biotech for a training period supported by the Barcelona Science Park program “Spend the summer at the Park !”. Laia is student of Pharmacy at the University of Barcelona.
SOM closes its first funding round with the investment of the venture capital firm Innova31 and six business angels. A second round is expected for late 2011.